Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 21 February 2027
- Last conf. stmt
- 7 February 2026
Centessa Pharmaceuticals Limited
- Incorporated
- 26 October 2020 (6 years)
- Previously known as
- United Medicines Biopharma Limited (until 17 February 2021)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Controlled by
- Details protected
- Accounts type
- Group
- Region
- South East
- Address
- Lilly House BasingviewBasingstokeHampshireRG21 4FA
Charges
- Total
- 8
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 8
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 24 June 2026
American
Born February 1979 (47)
Director · Appointed 24 June 2026
American
Born November 1978
Officer history (15 former)
7 September 2026
Resigned Hussain, Iqbal as Secretary
24 June 2026
24 June 2026
24 June 2026
Resigned Accardi, Mario Alberto, Dr as Director
24 June 2026
Resigned Goyal, Arjun, Dr as Director
24 June 2026
Resigned Hukkelhoven, Mathias as Director
24 June 2026
Resigned Zbar, Brett, Dr as Director
24 June 2026
Resigned Stuckley, Carol as Director
24 June 2026
Resigned Kulkarni, Samarth as Director
24 June 2026
24 June 2026
1 January 2026
Appointed Accardi, Mario Alberto, Dr as Director
1 January 2026
1 July 2022
Resigned Kantoff, Aaron as Director
1 July 2022
Appointed Hukkelhoven, Mathias as Director
16 February 2022
Resigned Califf, Robert Mckinnon as Director
2 June 2021
17 May 2021
Appointed Stuckley, Carol as Director
30 April 2021
Appointed Hussain, Iqbal as Secretary
30 April 2021
20 April 2021
Resigned Tait, Nicholas Alexander James as Secretary
22 February 2021
Appointed Kulkarni, Samarth as Director
22 February 2021
22 February 2021
Appointed Califf, Robert Mckinnon as Director
29 January 2021
Appointed Goyal, Arjun, Dr as Director
29 January 2021
29 January 2021
Appointed Zbar, Brett, Dr as Director
29 January 2021
Appointed Kantoff, Aaron as Director
29 January 2021
20 November 2020
26 October 2020
26 October 2020
Appointed Tait, Nicholas Alexander James as Secretary
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Details protected
Exemptions
Former controllers (1)
29 January 2021
Group structure 3 companies
Ownership group derived from the Companies House PSC register
Centessa Pharmaceuticals Limited This company
Centessa Pharmaceuticals (UK) Limited Owns 75–100% of shares
Apcintex Limited Owns 75–100% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 7 September 2026 | Re-registration from a public company to a private limited company | |||
| 7 September 2026 | Certificate of re-registration from Public Limited Company to Private | |||
| 7 September 2026 | Re-registration of Memorandum and Articles | |||
| 7 September 2026 | Termination of appointment of a secretary | |||
| 7 September 2026 | Resolutions |
Some other companies at this address
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →